Why relationships are key in rare disease patient engagement
pharmaphorum
MAY 7, 2021
Real-world data is a vital part of rare disease drug development, but to get a true picture of patients’ unmet needs pharma should take a broader view of their lived experiences, says Xperiome’s Jeremy Edwards. He says he would like to see the industry engaging rare disease patients at every stage of drug development.
126 
Let's personalize your content